151 related articles for article (PubMed ID: 35286011)
21. circRNA hsa_circ_104566 Sponged miR-338-3p to Promote Hepatocellular Carcinoma Progression.
Liu G; Guo W; Rao M; Qin J; Hu F; Li K
Cell Transplant; 2020; 29():963689720963948. PubMed ID: 33028110
[TBL] [Abstract][Full Text] [Related]
22. MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer.
Noh JH; Chang YG; Kim MG; Jung KH; Kim JK; Bae HJ; Eun JW; Shen Q; Kim SJ; Kwon SH; Park WS; Lee JY; Nam SW
Cancer Lett; 2013 Jul; 335(2):455-62. PubMed ID: 23499894
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4).
Wang G; Sun Y; He Y; Ji C; Hu B; Sun Y
Int J Clin Exp Pathol; 2015; 8(1):337-44. PubMed ID: 25755720
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinoma.
Zhang W; Liu K; Liu S; Ji B; Wang Y; Liu Y
Tumour Biol; 2015 Dec; 36(12):9779-88. PubMed ID: 26156803
[TBL] [Abstract][Full Text] [Related]
25. HnRNPU-AS1 inhibits the proliferation, migration and invasion of HCC cells and induces autophagy through miR-556-3p/ miR-580-3p/SOCS6 axis.
Zhang L; Zhao Y; Guan H; Zhang D
Cancer Biomark; 2022; 34(3):443-457. PubMed ID: 35275521
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma.
Wang W; Lin H; Zhou L; Zhu Q; Gao S; Xie H; Liu Z; Xu Z; Wei J; Huang X; Zheng S
Eur J Surg Oncol; 2014 Nov; 40(11):1586-94. PubMed ID: 24290372
[TBL] [Abstract][Full Text] [Related]
27. miR-144-3p represses hepatocellular carcinoma progression by affecting cell aerobic glycolysis via FOXK1.
Xing B; Shen C; Yang Q; Wang Z; Tan W
Int J Exp Pathol; 2023 Jun; 104(3):117-127. PubMed ID: 36806218
[TBL] [Abstract][Full Text] [Related]
28. Silencing of lncRNA CRNDE attenuates nonsmall-cell lung cancer progression by mediating the miR-455-3p/HDAC2 axis.
Li N; Chen XJ; Zeng YH; Zeng LP; Hu K; Chen LJ
Kaohsiung J Med Sci; 2022 Aug; 38(8):749-760. PubMed ID: 35611803
[TBL] [Abstract][Full Text] [Related]
29. miR-34c-3p inhibits cell proliferation, migration and invasion of hepatocellular carcinoma by targeting MARCKS.
Song J; Wang Q; Luo Y; Yuan P; Tang C; Hui Y; Wang Z
Int J Clin Exp Pathol; 2015; 8(10):12728-37. PubMed ID: 26722462
[TBL] [Abstract][Full Text] [Related]
30. MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C.
Tao J; Liu Z; Wang Y; Wang L; Yao B; Li Q; Wang C; Tu K; Liu Q
Biomed Pharmacother; 2017 Sep; 93():420-428. PubMed ID: 28666208
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-450b-3p inhibits cell growth by targeting phosphoglycerate kinase 1 in hepatocellular carcinoma.
Chen Z; Zhuang W; Wang Z; Xiao W; Don W; Li X; Chen X
J Cell Biochem; 2019 Nov; 120(11):18805-18815. PubMed ID: 31222833
[TBL] [Abstract][Full Text] [Related]
32. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
[TBL] [Abstract][Full Text] [Related]
33. MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma.
Dang S; Zhou J; Wang Z; Wang K; Dai S; He S
Biomed Pharmacother; 2018 Oct; 106():966-975. PubMed ID: 30170358
[TBL] [Abstract][Full Text] [Related]
34. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-27a-3p inhibits cell viability and migration through down-regulating DUSP16 in hepatocellular carcinoma.
Li JM; Zhou J; Xu Z; Huang HJ; Chen MJ; Ji JS
J Cell Biochem; 2018 Jul; 119(7):5143-5152. PubMed ID: 29143999
[TBL] [Abstract][Full Text] [Related]
36. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
Jin J; Liu H; Jin M; Li W; Xu H; Wei F
Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of circ_0021093 circular RNA forecasts an unfavorable prognosis and facilitates cell progression by targeting the miR-766-3p/MTA3 pathway in hepatocellular carcinoma.
Liu L; Qi X; Gui Y; Huo H; Yang X; Yang L
Gene; 2019 Sep; 714():143992. PubMed ID: 31330234
[TBL] [Abstract][Full Text] [Related]
38. Silence of lncRNA HEIH suppressed liver cancer cell growth and metastasis through miR-199a-3p/mTOR axis.
Ma Y; Cao D; Li G; Hu J; Liu X; Liu J
J Cell Biochem; 2019 Oct; 120(10):17757-17766. PubMed ID: 31144384
[TBL] [Abstract][Full Text] [Related]
39. Catalpol inhibits cell proliferation, invasion and migration through regulating miR-22-3p/MTA3 signalling in hepatocellular carcinoma.
Zhao L; Wang Y; Liu Q
Exp Mol Pathol; 2019 Aug; 109():51-60. PubMed ID: 31145886
[TBL] [Abstract][Full Text] [Related]
40. Up-regulation of miR-10b-3p promotes the progression of hepatocellular carcinoma cells via targeting CMTM5.
Guan L; Ji D; Liang N; Li S; Sun B
J Cell Mol Med; 2018 Jul; 22(7):3434-3441. PubMed ID: 29691981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
